| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.06 | 0.06 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.06 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.07 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.07 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.07 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.07 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.064 | 0.07 |